Today: 21 May 2026
Barclays Shares Slump 5% in FTSE 100 Rout – Is It a Golden Buying Opportunity?
22 October 2025
3 mins read

Barclays Q3 Profit Tops Forecast, Unveils £500m Buyback – Shares Jump, Analysts Bullish

  • Q3 results: Total income £7.2bn (+9% YoY, beating ~£7bn consensus); profit before tax £2.1bn (–7% YoY) after higher provisions.
  • Year-to-date: Nine-month pre-tax profit £7.3bn (up 14% YoY) with attributable profit £4.98bn (+14%), showing strong momentum.
  • Buybacks: Announced a £500m share buyback in Q3 (added to £1bn H1 buybacks) and will make buybacks quarterly, as part of a £10bn shareholder return plan through 2026. CET1 capital remains high (~14%) and RoTE guidance for 2025 was raised above 11%.
  • Stock reaction: Barclays stock jumped ~2.6–3% on the news to about 374p. The shares are up roughly 37% so far in 2025 (and 52% over the last year). At today’s levels, analysts’ average 12-month price targets (~416–425p) imply ~15–20% upside.
  • Analyst outlook: Market consensus remains a “Buy”. TipRanks notes a recent Barclays stock target of ~425ptipranks.com, and technical analysts similarly point to ~400–420p levelsts2.tech. HSBC, Bank of America and others recently reiterated positive views on UK banks.

Strong Q3 results despite charges

Barclays’ Q3 results (to 30 Sept) surpassed expectations. Total income rose to £7.2bn, a 9% year-on-year increase, helped by robust trading and higher net interest income. This beat internal forecasts of around £7bn. However, Barclays took extra charges: it raised motor-finance redress provisions to £325m (an extra £235m provision) and also booked a £110m credit charge linked to the collapse of US auto-dealer Tricolor. These drove pre-tax profit down to £2.1bn (–7% YoY), roughly in line with analysts’ models.

In context Barclays’ year-to-date performance remains strong. Profit before tax for the first nine months was £7.3bn (from £6.4bn a year ago), with attributable profit up 14% to £4.98bnts2.tech. CEO C.S. Venkatakrishnan highlighted this resilience, noting the bank’s “robustly and consistently generating capital for our shareholders” over the past quartersreuters.com. Return on tangible equity (RoTE) came in at about 10.6% for Q3 and 12.3% year-to-datets2.tech. Barclays responded by upgrading its 2025 RoTE target to above 11% and keeping 2026 guidance above 12%ts2.tech.

New buyback program boosts returns

One of the standout surprises was Barclays’ commitment to ramp up share buybacks. The bank announced a £500m share repurchase for Q3, on top of the £1bn buyback it completed in H1. More notably, management said it will shift to quarterly buyback announcements going forward, accelerating its plan to return £10bn of capital to investors by 2026. As a result, the pro-forma CET1 capital ratio (around 13.9%) remains strong even after the buyback. Barclays’ strategic focus on capital returns – skewed to buybacks rather than dividends – means a shrinking share count and rising per-share payouts over time.

The buyback and strong capital position comforted investors. On Oct 22, Barclays shares jumped about 2.6% at the open to ~373.95p. By midday the stock was up roughly 3%, lifting FTSE 100 bank indexes. Analysts note that with Barclays already delivering roughly half of its 2025 shareholder-return goal, dividends will also grow on a narrower share base. In fact, Barclays paid a 3p half-year dividend and analysts expect around 10–10.5p total in 2025, implying a ~2.7–3% yield on today’s price.

Stock outlook and analyst sentiment

Despite near-term charges, most analysts remain bullish on Barclays’ equity. The consensus “Buy” rating reflects the lender’s diversified business mix and improving profitability. For example, RBC’s Benjamin Toms welcomed Barclays’ broad income streams given uncertainty around the UK budget, though he cautioned that its US corporate lending will face more scrutinycityam.com. Matt Britzman at Hargreaves Lansdown sums up the view: “Barclays’ latest results show a bank quietly outperforming despite headline noise,” noting that the one-off motor-finance charge was largely anticipated by marketscityam.comreuters.com.

Technicals and targets are upbeat. TS2 TechStock analysts note Barclays shares have climbed from the low 200p range earlier this year to the 370s, and chart patterns suggest momentum could carry toward ~400p. TipRanks reports that the latest analyst price target is about 425p. With Barclays trading around 374p post-results, that implies roughly 13% upside, plus an attractive yield. Several brokers (including Goldman Sachs, JPMorgan and Citi) rate Barclays as a top UK bank pick for 2026. In short, the consensus is that today’s pullback offers a buying opportunity, not a warning signal – analysts believe underlying fundamentals remain intact.

Sources: Barclays Q3 reports and market reaction; City A.M., Reuters, TechStock² and TipRanks analysis.

Stock Market Today

  • SpaceX IPO Filing Reveals Financials, Musk Could Become First Trillionaire
    May 20, 2026, 7:08 PM EDT. SpaceX filed for an initial public offering (IPO), disclosing its finances and board members for the first time. The company reported $18.7 billion in revenue for 2025, up 33% year-on-year, but posted a net loss of $4.9 billion, reversing a $791 million profit in 2024. First-quarter 2026 losses reached $4.3 billion on $4.7 billion revenue. The IPO, trading as SPCX, may become the largest ever, potentially boosting Elon Musk's wealth to trillionaire status. SpaceX aims to fund its ambitious plans including Starlink satellite network expansion, AI infrastructure, and establishing extraterrestrial colonies.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
OpenAI’s DevDay Bombshells: No-Code AgentKit, ChatGPT App Store & Jony Ive’s AI Vision
Previous Story

OpenAI’s AI Browser Bombshell Sends Google Shares Tumbling – AI Browser Wars Ignite

Hungarian Astronaut Builds Super-Muscles with Futuristic EMSCULPT NEO Device
Next Story

Hungarian Astronaut Builds Super-Muscles with Futuristic EMSCULPT NEO Device

Go toTop